- 01IBS is diagnosed by its pattern, not by everything coming back normal
The ACG suggests a positive diagnostic strategy: when the Rome IV symptom pattern is present and there are no warning signs, IBS can be diagnosed directly, with a few targeted tests, rather than after ruling out every possible disease. Normal results do not prove IBS on their own, and an abnormal result does not fit IBS; they answer different questions.
- 02The tests are there to rule out look-alikes
Celiac antibodies, a blood count, CRP and fecal calprotectin look for celiac disease, anemia and inflammatory bowel disease, the conditions that most often mimic IBS. IBS does not cause inflammation or damage the intestine, so a high calprotectin or a low hemoglobin points away from IBS and toward further tests.
- 03Red flags decide colonoscopy, not symptom severity
Severe IBS pain alone is not a reason for colonoscopy in a younger adult. Blood in the stool, weight loss, anemia, symptoms waking you at night, fever, a family history of colon cancer or inflammatory bowel disease, or new symptoms later in life are what move someone toward a scope.
Irritable bowel syndrome (IBS) is a common, long-term condition that causes repeated belly pain tied to bowel movements, along with diarrhea, constipation or both. 45 It is now classed as a disorder of gut-brain interaction: the bowel looks normal on tests, but the way it moves and the way its nerves sense pain are out of tune. 15 IBS can be painful and disruptive, but it does not damage the intestine or lead to other diseases. 5 It is diagnosed from a symptom pattern called the Rome IV criteria, backed by a few targeted tests that rule out celiac disease and inflammatory bowel disease. 13 What to do next: track your symptoms for a few weeks (pain days, stool type, triggers, anything that wakes you at night) and bring that record to your clinician, along with any warning signs listed below.
Symptoms of IBS
IBS symptoms usually come and go over months or years, often flaring with stress, certain foods or the menstrual cycle. The left column lists the typical pattern; the right column lists features that do not fit IBS and need a clinician's look. Associations only: these lists cannot diagnose IBS or rule anything out. 56
- Belly pain or cramping that is related to bowel movements
- Diarrhea, constipation, or swings between the two
- Bloating and a swollen-feeling belly
- A feeling that the bowel has not fully emptied
- Whitish mucus in the stool
- Worse symptoms around periods
- Blood in the stool, or black, tarry stools
- Unintentional weight loss
- Diarrhea or pain that wakes you from sleep
- Fever, or anemia on a blood test
- New symptoms starting later in life
- A family history of colon cancer, inflammatory bowel disease or celiac disease
Get care the same day Seek same-day care for heavy or ongoing rectal bleeding, black or tarry stools, severe belly pain that does not ease, a swollen hard belly with vomiting, fever with bloody diarrhea, or signs of dehydration such as very little urine, dizziness or confusion. These are not IBS symptoms and need prompt assessment.
Symptom pattern from NIDDK and warning signs from NIDDK and the ACG 2021 guideline 256. Associations only, never a way to diagnose yourself.
What is IBS, and who gets it?
IBS is defined by symptoms, not by a visible abnormality. NIDDK describes it as "a group of symptoms that occur together, including repeated pain in your abdomen" and changes in bowel movements. 4 The British Society of Gastroenterology reclassified it in 2021 as a disorder of gut-brain interaction rather than a functional gastrointestinal disorder, reflecting research on how the gut, its nerves and the brain signal to each other. 9
How common IBS is depends on the definition. NIDDK cites studies suggesting about 12% of people in the United States have IBS, using older, broader criteria. 4 Women are up to twice as likely as men to develop it, and people under 50 more likely than those over 50. 4 People with IBS often have other conditions too: chronic pain conditions such as fibromyalgia, reflux or indigestion, and anxiety or depression. 4
No single cause has been found, and the mix differs between people. NIDDK lists problems with gut-brain interaction that change how the gut moves and senses pain, stressful or difficult early life events, anxiety and depression, bacterial infections of the digestive tract, small intestinal bacterial overgrowth (SIBO), food intolerances or sensitivities, and genes. 5 An IBS that begins after a bout of food poisoning or gastroenteritis is a recognized pattern, one reason a clinician will ask how symptoms started.
How IBS is diagnosed: the Rome IV criteria
Clinicians diagnose IBS from the Rome IV criteria, published by the Rome Foundation. The core requirement is quoted here word for word, because each part matters: "Recurrent abdominal pain on average at least 1 day/week in the last 3 months," associated with two or more of three features. 3
| Rome IV requirement | What it means in plain words |
|---|---|
| Recurrent belly pain, on average at least 1 day a week in the last 3 months 3 | Bloating or discomfort alone is not enough; pain is required |
| Pain related to defecation 3 | The pain changes, often eases, around bowel movements |
| Pain linked to a change in stool frequency 3 | Going more or less often when the pain is present |
| Pain linked to a change in stool form 3 | Looser or harder stools when the pain is present |
| Two or more of the three features above 3 | One link to bowel habits is not enough |
| Criteria met for the last 3 months, with symptoms starting at least 6 months before diagnosis 3 | A long-running pattern, not a recent change; NIDDK notes doctors may diagnose earlier in some cases 6 |
The ACG's first IBS guideline, published in 2021, makes this pattern the center of diagnosis. It states: "We suggest that a positive diagnostic strategy as compared to a diagnostic strategy of exclusion be used to improve time to initiating appropriate therapy." 1 In practice, a clinician who sees the Rome IV pattern, finds no warning signs on history and exam, and gets normal results on a few targeted tests can diagnose IBS and start treatment, without a long chain of scans and scopes. NIDDK puts it plainly: "In most cases, doctors don't use tests to diagnose IBS." 6
The IBS subtypes: IBS-C, IBS-D and IBS-M
IBS is split into subtypes by the stool pattern on days when bowel movements are abnormal, and the ACG suggests that getting the subtype right improves treatment, because many therapies only help one subtype. 2 NIDDK defines the subtypes by which stool types make up more than a quarter of abnormal bowel movements. 4 Some searches ask about "IBS-A," an older name for alternating IBS, which now falls under IBS-M.
| Subtype | Stool pattern on abnormal days | Treatments aimed at it |
|---|---|---|
| IBS-C (constipation) | Hard or lumpy stools in more than a quarter of abnormal bowel movements 4 | Soluble fiber, laxatives, prescription secretagogues 27 |
| IBS-D (diarrhea) | Loose or watery stools in more than a quarter of abnormal bowel movements 4 | Loperamide, rifaximin, eluxadoline, alosetron 714 |
| IBS-M (mixed) | Both hard or lumpy and loose or watery stools, each in more than a quarter 4 | Treatment follows whichever symptom is leading at the time |
| IBS-U (unclassified) | Meets IBS criteria but fits none of the patterns above | Treated by main symptom |
The tests that rule out other causes
The few tests that matter in IBS are there to rule out the conditions that mimic it, chiefly celiac disease and inflammatory bowel disease (IBD), the umbrella term for Crohn's disease and ulcerative colitis. The ACG recommends celiac blood tests for people with IBS and diarrhea symptoms, and suggests checking fecal calprotectin (or fecal lactoferrin) and C-reactive protein in suspected IBS with diarrhea to rule out IBD. 2 The British Society of Gastroenterology adds a complete blood count and CRP or ESR to the first-line primary care workup. 9
| Marker | What it shows | Typical cutoff | First-line or add-on |
|---|---|---|---|
| Fecal calprotectin | Inflammation in the bowel wall; normal in IBS 11 | Under 50 µg/g normal; above 120 abnormal 12 | First-line with diarrhea 2 |
| Fecal lactoferrin | Another stool marker of bowel inflammation | Lab-specific; negative or positive | Alternative to calprotectin 2 |
| CRP (C-reactive protein) | Inflammation anywhere in the body | Above the lab's range | First-line with diarrhea 2 |
| ESR (sedimentation rate) | A slower, broader inflammation marker | Above the lab's range | Alternative to CRP 9 |
| tTG-IgA with total IgA | Celiac disease; total IgA checks the test can be trusted | Lab-specific positive cutoff | First-line with diarrhea 2 |
| Hemoglobin and MCV | Anemia, a warning sign that does not fit IBS 6 | Below the lab's range | First-line 9 |
| Ferritin | Iron stores; low iron points to blood loss or celiac disease | Below the lab's range | Add-on when anemia or low iron |
| TSH | Thyroid problems, which can also change bowel habits | Outside the lab's range | Not in the routine IBS workup in the ACG or BSG guidance; checked when other symptoms point to the thyroid 29 |
| FIT (fecal immunochemical test) | Hidden blood in the stool | Positive or negative | Colorectal screening; not an IBS test |
Then read the results together. The inflammation markers guide explains CRP and ESR, and the CBC guide the blood count.
| Pattern | What it usually means |
|---|---|
| Rome IV symptoms, normal blood count, CRP, celiac tests and calprotectin, no warning signs | Fits IBS; a positive diagnosis can be made 12 |
| Calprotectin above 120 µg/g, or a raised CRP | Active inflammation; IBD, infection or another cause needs looking into, often by colonoscopy 1112 |
| Calprotectin 50 to 120 µg/g | Borderline; may be mild inflammation or a medicine effect; often repeated in 4 to 6 weeks 12 |
| Positive tTG-IgA | Celiac disease is likely; see the celiac disease page |
| Low hemoglobin or ferritin | Anemia or iron deficiency; a warning sign that needs a cause found 6 |
| Abnormal TSH | A thyroid problem may be contributing to bowel changes; the clinician looks into it before settling on IBS |
| Positive FIT | Hidden blood; colonoscopy is the usual next step |
Tests the ACG recommends against in typical IBS
- Routine stool testing for infections (enteric pathogens) in everyone with IBS. 2
- Routine colonoscopy in people with IBS symptoms younger than 45 without warning signs; age-appropriate colon cancer screening still applies. 2
- Food allergy and food sensitivity tests, unless there are reproducible symptoms that suggest a true food allergy. 2
- The British Society of Gastroenterology also advises against routine testing for small intestinal bacterial overgrowth or pancreatic insufficiency when symptoms are typical of IBS. 9
Consumer gut microbiome tests are not part of the guideline workup for IBS, and no microbiome pattern diagnoses it. If you already have such a report, the gut microbiome test guide explains what the diversity scores and bacterial names can and cannot tell you.
Fecal calprotectin under 50, 50 to 120, or over 120: what the number means
Fecal calprotectin is a protein released by white blood cells in an inflamed bowel, measured in a small stool sample. MedlinePlus explains that its main use is telling IBD apart from IBS, because "only IBD involves inflammation." 11 Cutoffs vary by lab, so check the range on your report; the bands below come from one hospital laboratory handbook. 12
Where an example fecal calprotectin of 80 µg/g fallsµg/g
- Calprotectin under 50 µg/g: not suggestive of active bowel inflammation, which fits IBS when the symptom pattern matches. 12 MedlinePlus notes false negatives can occur, mostly in children. 11
- Calprotectin 50 to 120 µg/g: borderline. NSAID painkillers, aspirin and proton pump inhibitors can push results into this band. 12
- Calprotectin above 120 µg/g: suggests active inflammation. IBD is one cause; infections such as C. diff, celiac disease and colorectal cancer are others, so a clinician usually arranges further tests. 1112
- Calprotectin in the hundreds or higher: very high levels are mainly linked to IBD and some gut infections. 11
IBS vs IBD and other look-alikes
IBS or IBD: inflammation markers tell them apart
| Look-alike | What overlaps with IBS | The test that tells them apart |
|---|---|---|
| Celiac disease | Bloating, diarrhea, pain | tTG-IgA with total IgA, while eating gluten 2 |
| Inflammatory bowel disease | Pain, diarrhea | Fecal calprotectin, CRP, colonoscopy 211 |
| Microscopic colitis | Watery diarrhea, often in women over 50 | Colonoscopy with biopsies, even if the bowel looks normal 9 |
| Bile acid diarrhea | Diarrhea, often at night or after gallbladder removal | Specialist bile acid testing 9 |
| Lactose intolerance or SIBO | Bloating, gas, loose stools | Hydrogen breath test 6 |
| Hyperthyroidism | Frequent loose stools, weight loss | TSH and free T4, when other thyroid symptoms are present; not part of the routine IBS workup |
| Hypothyroidism | Constipation, tiredness | TSH, when other thyroid symptoms are present; not part of the routine IBS workup |
| Iron deficiency and anemia | Tiredness alongside gut symptoms | Blood count and ferritin; anemia is a warning sign 6 |
| Colorectal cancer | Change in bowel habit | FIT, colonoscopy; age and red flags guide it 2 |
IBS treatment: what helps, and how strong the evidence is
IBS treatment is matched to the main symptom and subtype, and most people try a few approaches before finding what works. The ACG guideline graded 16 treatment questions using GRADE, a standard system that rates both how firmly a guideline recommends something and how good the evidence is. 1 The grades below translate those ratings into Strong, Moderate, Limited or Not supported.
| Approach | What the evidence shows | Strength | Cautions |
|---|---|---|---|
| Soluble fiber (psyllium, also called ispaghula) | ACG suggests soluble, but not insoluble, fiber for overall symptoms (moderate-quality evidence); BSG lists it first-line with exercise 29 | Moderate | Increase gradually to limit gas; insoluble wheat bran is not recommended 9 |
| Regular exercise | First-line in the BSG guideline; NIDDK lists physical activity, stress management and sleep 79 | Limited | Few side effects |
| Low FODMAP diet, limited trial | ACG recommends a limited trial for overall symptoms; evidence quality rated very low 2 | Limited | Best with a dietitian; strict phase is short; not a lifelong diet 13 |
| Peppermint oil | ACG suggests it for overall symptoms (low-quality evidence); NIDDK lists coated capsules for pain 27 | Limited | Can worsen heartburn; ask about interactions |
| Gut-directed psychotherapy (CBT, gut-directed hypnotherapy) | ACG suggests it for overall symptoms; evidence quality rated very low 12 | Limited | Access varies; works alongside other treatments |
| Tricyclic antidepressants, low dose (prescription) | ACG recommends them for overall symptoms (strong, moderate-quality evidence); they act on gut pain nerves 2 | Strong | Prescription; side effects such as dry mouth and constipation; the clinician decides |
| Prescription options for IBS-C (linaclotide, plecanatide, lubiprostone) | ACG recommends guanylate cyclase and chloride channel activators 12 | Strong | Diarrhea is the common side effect; the clinician decides. Tegaserod, also in the 2021 ACG guideline, was withdrawn from the US market in 2022 |
| Prescription options for IBS-D (rifaximin, eluxadoline, alosetron) | ACG recommends rifaximin; the AGA gives conditional recommendations for all three 114 | Moderate | Alosetron is restricted to women with severe symptoms 27 |
| Loperamide for diarrhea | AGA conditional recommendation, very low certainty; BSG lists it 914 | Limited | Helps stool frequency more than pain |
| Antispasmodics | ACG recommends against them for overall symptoms; AGA conditional for, low certainty 214 | Limited | May help cramping for some |
| Probiotics | ACG suggests against for overall symptoms; AGA: only in clinical trials, a knowledge gap 28 | Not supported | Cost; products vary widely |
| SSRIs (a type of antidepressant) | AGA conditional recommendation against for IBS-D, low certainty 14 | Not supported | May still be used for anxiety or depression |
| Fecal transplant | ACG recommends against for IBS 2 | Not supported | Not an IBS treatment outside research |
Prescription medicines in the table are named so you recognize them; whether any fits you, and which, is a decision for your clinician, who weighs your subtype, other conditions and side effects. Do not start, stop or combine prescription medicines without them.
The low FODMAP diet for IBS in three steps
FODMAPs are fermentable oligosaccharides, disaccharides, monosaccharides and polyols: short-chain carbohydrates that some people absorb poorly, so gut bacteria ferment them into gas and they draw water into the bowel. 1 They are found in foods such as wheat, onions, garlic, beans, some fruits and milk. The diet is a short test, not a permanent way of eating, and Monash University, which developed it, advises doing it with a dietitian. 13
- 1Step 1: low FODMAPSwap high-FODMAP foods for low-FODMAP ones for 2 to 6 weeks, under a dietitian's guidance. If symptoms do not improve, the diet is unlikely to be the answer. 13
- 2Step 2: reintroductionBring FODMAP groups back one at a time to see which trigger symptoms; this takes most people around 6 to 8 weeks. 13
- 3Step 3: personalizationSettle on a longer-term diet that includes everything you tolerate and limits only your own triggers. 13
A strict low FODMAP diet cuts out many high-fiber foods, so staying in step 1 for months risks a narrow diet. People with a history of eating disorders, or who are already losing weight, should raise that with their clinician before starting any restrictive diet. Cutting out wheat before celiac testing can also make celiac blood tests falsely negative, so celiac testing comes first, as the celiac disease page explains.
Probiotics and magnesium: where the supplement guides fit
Probiotics are the supplement most often tried for IBS, and the evidence is the weakest. The AGA states: "In symptomatic children and adults with irritable bowel syndrome, we recommend the use of probiotics only in the context of a clinical trial," because the trials used many different strains and gave inconsistent results. 8 The probiotics guide covers which uses do have evidence and how products differ. Magnesium also comes up in searches about IBS with constipation, because some over-the-counter laxatives contain magnesium. NIDDK lists laxatives in general among the options for IBS-C 7, but none of the IBS guidelines cited on this page grades magnesium as an IBS treatment, and the ACG suggests against another common laxative, polyethylene glycol, for overall IBS-C symptoms. 2 The magnesium guide covers the forms and the main caution: people with kidney disease can build up magnesium to unsafe levels, so any magnesium product is a conversation with a clinician first.
We suggest that a positive diagnostic strategy as compared to a diagnostic strategy of exclusion be used to improve time to initiating appropriate therapy.
Monitoring and when to retest
Once IBS is diagnosed, routine repeat testing is not needed while the pattern stays the same, because IBS does not damage the bowel. 5 Retesting has a purpose when something changes. See why a trend beats a single reading for how to read a repeat result.
| What gets rechecked | When | Why |
|---|---|---|
| Fecal calprotectin | In 4 to 6 weeks after a borderline result 12 | Separates a passing rise from ongoing inflammation |
| Hemoglobin and ferritin | If tiredness, paleness or new symptoms appear | Anemia is a warning sign that does not fit IBS 6 |
| tTG-IgA | If diarrhea symptoms persist and celiac testing was never done, or was done while gluten-free | Celiac disease is a common look-alike 2 |
| CRP | With new diarrhea, fever or night symptoms | Points to inflammation rather than IBS 2 |
| Colorectal cancer screening (FIT or colonoscopy) | From the standard screening age, or earlier with red flags | IBS does not remove the need for routine screening 29 |
| Symptom diary | Before and after each treatment trial | Shows whether a change helped; most trials need several weeks |
Questions to ask your clinician
- Do my symptoms meet the Rome IV criteria, and which subtype am I: IBS-C, IBS-D or IBS-M?
- Have celiac disease and inflammatory bowel disease been ruled out? Was my total IgA checked with the celiac test?
- Should we check fecal calprotectin and CRP, given my diarrhea?
- Do any of my symptoms count as warning signs that mean I need a colonoscopy?
- Is a low FODMAP trial a good fit, and can you refer me to a dietitian?
- Would soluble fiber, peppermint oil or gut-directed therapy suit my main symptom?
- Which prescription options exist for my subtype, and what are their side effects?
- When should I be screened for colorectal cancer?
For more depth, the gut hub gathers the digestive markers, the inflammation hub covers CRP and related tests, and the celiac disease page covers the antibody test in full.
This page is general education, not medical advice or a diagnosis. The clinician who knows your history and full results is the right person to interpret your tests and decide on treatment with you.
Educational only: LifeFrom explains lab results and does not diagnose or treat IBS. Heavy rectal bleeding, black stools, severe belly pain or signs of dehydration need same-day care, and weight loss, anemia, fever or night-time symptoms need a prompt appointment. Find the cause with a clinician before starting anything, including supplements or a restrictive diet.
Citations
- Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021;116(1):17-44.
- MDCalc. ACG guideline summary: management of irritable bowel syndrome (2021), recommendation statements with strength and quality of evidence.
- Rome Foundation. Rome IV criteria: C1, irritable bowel syndrome.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Definition and facts for irritable bowel syndrome.
- NIDDK. Symptoms and causes of irritable bowel syndrome.
- NIDDK. Diagnosis of irritable bowel syndrome.
- NIDDK. Treatment for irritable bowel syndrome.
- Su GL, Ko CW, Bercik P, et al. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):697-705.
- Ebell MH. British Society of Gastroenterology guidelines for the management of irritable bowel syndrome (summary of Vasant DH et al., Gut 2021;70:1214-1240). Am Fam Physician. 2022.
- Sperber AD, Bangdiwala SI, Drossman DA, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study. Gastroenterology. 2021;160(1):99-114.
- MedlinePlus Lab Tests. Calprotectin stool test. US National Library of Medicine.
- University of Iowa Health Care, Pathology Laboratory Services Handbook. Calprotectin, fecal: reference range and interpretation.
- Monash University FODMAP. The 3 steps of the FODMAP diet.
- Lembo A, Sultan S, Chang L, et al. AGA clinical practice guideline on the pharmacological management of irritable bowel syndrome with diarrhea. Gastroenterology. 2022;163(1):137-151.
Educational context only, not medical advice or a diagnosis. Always discuss your results with a clinician.


